Sorry, you need to enable JavaScript to visit this website.
Skip to main content

CSL Vifor is committed to improving the lives of patients around the world with the development of innovative pharmaceutical products. Our passion, values and ethics continue to drive our approach to research and development. It is important for us to provide you with data about how treatments may impact patients when used in clinical practice. Find out about our ongoing phase IV real world evidence studies.

Hyperkalemia

CARE-HK in HF

Cardiovascular and renal treatment in heart failure patients with hyperkalemia or at high risk of hyperkalemia

View study summary
CKD-MBD and SHPT

PORTRAY

ERC non-interventional study (NIS) on effectiveness in ND-CKD SHPT patients

View study summary